Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 745093, 8 pages
http://dx.doi.org/10.1155/2014/745093
Research Article

Fasting Hyperglycemia Increases In-Hospital Mortality Risk in Nondiabetic Female Patients with Acute Myocardial Infarction: A Retrospective Study

Department of Endocrinology and Metabolism, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong 519000, China

Received 18 April 2014; Revised 14 June 2014; Accepted 19 June 2014; Published 14 July 2014

Academic Editor: Alexandra Kautzky-Willer

Copyright © 2014 Guojing Luo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Marrugat, J. Sala, R. Masiá et al., “Mortality differences between men and women following first myocardial infarction,” Journal of the American Medical Association, vol. 280, no. 16, pp. 1405–1409, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Trappolini, F. M. Chillotti, R. Rinaldi et al., “Sex differences in incidence of mortality after acute myocardial infarction,” Italian Heart Journal, vol. 3, no. 7, pp. 759–766, 2002. View at Google Scholar · View at Scopus
  3. M. P. Savage, A. S. Krolewski, G. G. Kenien, M. P. Lebeis, A. R. Christlieb, and S. M. Lewis, “Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor,” The American Journal of Cardiology, vol. 62, no. 10, pp. 665–669, 1988. View at Publisher · View at Google Scholar · View at Scopus
  4. S. M. Donahoe, G. C. Stewart, C. H. McCabe et al., “Diabetes and mortality following acute coronary syndromes,” Journal of the American Medical Association, vol. 298, no. 7, pp. 765–775, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. P. C. Deedwania, M. I. Ahmed, M. A. Feller et al., “Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure,” European Journal of Heart Failure, vol. 13, no. 5, pp. 551–559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Aguilar, S. D. Solomon, L. Koøber et al., “Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the Valsartan in acute myocardial infarction (VALIANT) trial,” Circulation, vol. 110, no. 12, pp. 1572–1578, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ishihara, S. Kojima, T. Sakamoto et al., “Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era,” American Heart Journal, vol. 150, no. 4, pp. 814–820, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Kosiborod, S. S. Rathore, S. E. Inzucchi et al., “Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes,” Circulation, vol. 111, no. 23, pp. 3078–3086, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Ishihara, “Acute hyperglycemia in patients with acute myocardial infarction,” Circulation Journal, vol. 76, no. 3, pp. 563–571, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Ishihara, S. Kojima, T. Sakamoto et al., “Comparison of blood glucose values on admission for acute myocardial infarction in patients with versus without diabetes mellitus,” American Journal of Cardiology, vol. 104, no. 6, pp. 769–774, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. D. S. Pinto, A. H. Skolnick, A. J. Kirtane et al., “U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction,” Journal of the American College of Cardiology, vol. 46, no. 1, pp. 178–180, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. S. Nieminen, M. Bohm, M. R. Cowie et al., “Executive summary of the guidelines on the diagnosis and treatment of acute heart failure,” Italian Heart Journal, vol. 6, no. 4, pp. 218–254, 2005. View at Google Scholar
  13. A. Dziewierz, D. Giszterowicz, Z. Siudak, T. Rakowski, J. S. Dubiel, and D. Dudek, “Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction,” Clinical Research in Cardiology, vol. 99, no. 11, pp. 715–721, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. E. Capes, D. Hunt, K. Malmberg, and H. C. Gerstein, “Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview,” The Lancet, vol. 355, no. 9206, pp. 773–778, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. I. B. Squire, C. P. Nelson, L. L. Ng, D. R. Jones, K. L. Woods, and P. C. Lambert, “Prognostic value of admission blood glucose concentration and diabetes diagnosis on survival after acute myocardial infarction: results from 4702 index cases in routine practice,” Clinical Science, vol. 118, no. 8, pp. 527–535, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. R. Timmer, M. Hoekstra, M. W. N. Nijsten et al., “Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention,” Circulation, vol. 124, no. 6, pp. 704–711, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Cruz-Gonzalez, S. Chia, O. C. Raffel et al., “Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction,” Diabetes Research and Clinical Practice, vol. 88, no. 1, pp. 97–102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. E. Høfsten, B. B. Løgstrup, J. E. Møller, P. A. Pellikka, and K. Egstrup, “Abnormal glucose metabolism in acute myocardial infarction: influence on left ventricular function and prognosis,” JACC: Cardiovascular Imaging, vol. 2, no. 5, pp. 592–599, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. E. J. Bakker, T. M. Valentijn, and K. M. van de Luijtgaarden, “Type 2 diabetes mellitus, independent of insulin use, is associated with an increased risk of cardiac complications after vascular surgery,” Anaesth Intensive Care, vol. 41, no. 5, pp. 584–590, 2013. View at Google Scholar
  20. P. Lugomirski, H. Guo, N. K. Boom, L. R. Donovan, D. T. Ko, and J. V. Tu, “Quality of diabetes and hyperlipidemia screening before a first myocardial infarction,” Canadian Journal of Cardiology, vol. 29, no. 11, pp. 1382–1387, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Suleiman, H. Hammerman, M. Boulos et al., “Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study,” Circulation, vol. 111, no. 6, pp. 754–760, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Aronson, H. Hammerman, M. R. Kapeliovich et al., “Fasting glucose in acute myocardial infarction: incremental value for long-term mortality and relationship with left ventricular systolic function,” Diabetes Care, vol. 30, no. 4, pp. 960–966, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-W. Yang, Y.-J. Zhou, X.-M. Nie et al., “Effect of abnormal fasting plasma glucose level on all-cause mortality in older patients with acute myocardial infarction: results from the Beijing Elderly Acute Myocardial Infarction Study (BEAMIS),” Mayo Clinic Proceedings, vol. 86, no. 2, pp. 94–104, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. S. M. Donahoe, G. C. Stewart, C. H. McCabe et al., “Diabetes and mortality following acute coronary syndromes,” The Journal of the American Medical Association, vol. 298, no. 7, pp. 765–775, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. R. M. Jacoby and R. W. Nesto, “Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis,” Journal of the American College of Cardiology, vol. 20, no. 3, pp. 736–744, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. K. H. Mak, D. J. Moliterno, C. B. Granger et al., “Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries,” Journal of the American College of Cardiology, vol. 30, no. 1, pp. 171–179, 1997. View at Google Scholar
  27. H. L. Koek, S. S. Soedamah-Muthu, J. W. Kardaun et al., “Short-and long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus,” European Journal of Epidemiology, vol. 22, no. 12, pp. 883–888, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. S. T. Nauta, K. M. Akkerhuis, J. W. Deckers, and R. T. Van Domburg, “Short- and long-term mortality after myocardial infarction in patients with and without diabetes: changes from 1985 to 2008,” Diabetes Care, vol. 35, no. 10, pp. 2043–2047, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. R. T. C. E. Robinson, N. D. Harris, R. H. Ireland, S. Lee, C. Newman, and S. R. Heller, “Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia,” Diabetes, vol. 52, no. 6, pp. 1469–1474, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. H. D. White, H. R. Reynolds, A. C. Carvalho et al., “Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort,” American Heart Journal, vol. 163, no. 4, pp. 563–571, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. M. Madsen, M. Busk, H. M. Søndergaard et al., “Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy),” The American Journal of Cardiology, vol. 96, no. 11, pp. 1469–1475, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. G. A. Oswald, C. C. T. Smith, D. J. Betteridge, and J. S. Yudkin, “Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction,” British Medical Journal, vol. 293, no. 6552, pp. 917–922, 1986. View at Publisher · View at Google Scholar · View at Scopus
  33. L. M. Chu, R. M. Osipov, M. P. Robich et al., “Is hyperglycemia bad for the heart during acute ischemia?” Journal of Thoracic and Cardiovascular Surgery, vol. 140, no. 6, pp. 1345–1352, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Rodrigues, D. M. T. Figueroa, J. Fang et al., “Short-term diabetes attenuates left ventricular dysfunction and mortality rates after myocardial infarction in rodents,” Clinics, vol. 66, no. 8, pp. 1437–1442, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Moriyama, M. Ishihara, T. Noguchi et al., “Admission hyperglycemia is an independent predictor of acute kidney injury in patients with acute myocardial infarction,” Circulation Journal, vol. 78, no. 6, pp. 1475–1480, 2014. View at Google Scholar
  36. A. Scuteri, S. S. Najjar, M. Orru' et al., “Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 8, pp. 532–541, 2009. View at Publisher · View at Google Scholar · View at Scopus